COMMUNIQUÉS West-GlobeNewswire

Acumen Pharmaceuticals to Participate in the Stifel 2024 CNS Days
12/03/2024
CHARLOTTESVILLE, Va., March 12, 2024 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta [...]
Neurona Therapeutics to Present at Stifel 2024 Virtual CNS Days
12/03/2024
SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- Neurona Therapeutics , a clinical-stage biotherapeutics company advancing regenerative cell therapy candidates for the treatment of neurological disorders, today [...]
ASLAN Pharmaceuticals Announces $5 Million Registered Direct Offering
12/03/2024
SAN MATEO, Calif. and SINGAPORE, March 12, 2024 (GLOBE NEWSWIRE) -- ASLAN Pharmaceuticals Ltd. (Nasdaq: ASLN), a clinical-stage, immunology focused biopharmaceutical company developing innovative treatments to transform [...]
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
12/03/2024
TORONTO and EDMONTON, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that [...]
Aeterna Zentaris and Ceapro Merger Approved by Securityholders at Special Meetings
12/03/2024
TORONTO and EDMONTON, March 12, 2024 (GLOBE NEWSWIRE) -- Aeterna Zentaris Inc. (NASDAQ: AEZS) (TSX: AEZS) (“ Aeterna ”) and Ceapro Inc. (TSX-V: CZO; OTCQX: CRPOF) (“ Ceapro ”) are pleased to announce that [...]
UPDATE -- Fractyl Health Announces New Results From Its Rejuva® Platform Demonstrating Potent and Durable Effects of a Single Dose of a Human GLP-1 Pancreatic Gene Therapy Transgene Compared to Semaglutide in the db/db Mouse Model of Diabetes and Obesity
12/03/2024
Data provides first demonstration of glucose lowering and weight loss potency from pancreas-produced native human GLP-1, highlighting the capacity of pancreatic GLP-1 to provide metabolic control. The human GLP-1 [...]
Report of transactions of shares and related securities of Bavarian Nordic by persons holding managerial responsibilities and/or persons/companies closely associated with such
12/03/2024
COPENHAGEN, Denmark, March 12, 2024 – Bavarian Nordic A/S (OMX: BAVA) has today received information about the following transactions of the Company’s shares/related securities by persons holding managerial [...]
ARC Resources Ltd. donates $5 million to OWN.CANCER Campaign ahead of opening of new Arthur J.E. Child Comprehensive Cancer Centre in Calgary
12/03/2024
This is the campaign’s largest corporate gift and will support clinical trials and innovations in radiation oncology CALGARY, Alberta, March 12, 2024 (GLOBE NEWSWIRE) -- The Alberta Cancer Foundation, along with Alberta [...]
Fortrea signe un accord définitif pour céder les activités Endpoint Clinical et Patient Access à Arsenal Capital Partners
12/03/2024
Le projet de cession des activités Endpoint Clinical et Fortrea Patient Access permet à Fortrea de se recentrer sur son cœur de métier stratégique d’organisme de recherche contractuelle Création de solutions autonomes [...]
SaharaBets Partners with Birches Health to Increase Accessibility to Responsible Gaming Resources and Problem Gambling Treatment
12/03/2024
PHOENIX, Arizona, March 12, 2024 (GLOBE NEWSWIRE) -- SaharaBets and Birches Health announced the formation of a partnership focusing on proactive engagement and education in Responsible Gaming. The partnership provides [...]
Ibogaine By David Dardashti Announces New Algorithm to Address PTSD
12/03/2024
Groundbreaking Algorithm to Help Treat Trauma Victims MIAMI, March 12, 2024 (GLOBE NEWSWIRE) -- Ibogaine By David Dardashti , a company that specializes in helping people heal from trauma, has announced a revolutionary [...]
Astrocyte Pharmaceuticals Announces FDA Clearance of its Investigational New Drug Application for AST-004
12/03/2024
Green Light for Phase 2 Trial of AST-004 in Acute Ischemic Stroke Patients GROTON, Conn., March 12, 2024 (GLOBE NEWSWIRE) -- Astrocyte Pharmaceuticals Inc. , a clinical-stage biopharmaceutical company committed to [...]
Pennant Group to Participate in the 2024 Oppenheimer Healthcare MedTech & Services Conference
12/03/2024
EAGLE, Idaho, March 12, 2024 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant group of affiliated home health, hospice and senior living companies, announced today that it [...]
Psyence Group's NASDAQ Listed Associate, Psyence Biomedical, Receives Human Research Ethics Committee (HREC) Approval to Initiate Phase IIb Study
12/03/2024
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Psyence Group Inc (" Psyence Group ") (CSE: PSYG), a clinical-stage life science biotechnology company pioneering the use of nature-derived psilocybin in mental health and [...]
Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya
12/03/2024
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics , Inc., a clinical-stage biotechnology company committed to developing a patient-friendly treatment platform for people with peanut and other food [...]
BRIGHT GREEN ANNOUNCES PLANS FOR $250 MILLION EXPANSION OF ITS CONTROLLED SUBSTANCES DRUG PRODUCTION FACILITY IN GRANTS, NEW MEXICO AND OBTAINS $60 MILLION IN FINANCING
12/03/2024
GRANTS, NEW MEXICO, March 12, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation (Nasdaq: BGXX) (“Bright Green” or the “Company”) today announced that it has signed an agreement with Dalsem Greenhouse Technologies BV for [...]
Middlesex Recovery Earns Three-Year CARF Accreditation
12/03/2024
LEWISVILLE, Texas, March 12, 2024 (GLOBE NEWSWIRE) -- Middlesex Recovery is proud to announce that it has earned a Three-Year Accreditation from the Commission on Accreditation of Rehabilitation Facilities (CARF) for [...]
EverythingALS Launches the Vision 2030 AI Hub: Charting the Path to an ALS Cure and Advancing Neurodegenerative Disease Research
12/03/2024
Vision 2030 will utilize advanced technologies and an innovative operating model for research and drug development SAN FRANCISCO, March 12, 2024 (GLOBE NEWSWIRE) -- EverythingALS, a leading force in the fight against [...]
Health-ISAC Supports Health Industry Cybersecurity Strategic Plan
12/03/2024
Joint effort gives measurable objectives toward resilience within 5 years ORMOND BEACH, Fla., March 12, 2024 (GLOBE NEWSWIRE) -- Health-ISAC, a non-profit, member driven organization is pleased to contribute to the [...]

Pages